[Treatment of painful osseous crises of sickle cell anemia with an arteriolar vasodilator].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000188:drug therapy*; D001158:Arteries / Q000187:drug effects; D001847:Bone Diseases / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D002675:Child, Preschool; D004877:Ergoloid Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D004877:Ergoloid Mesylates
Traitement des crises duouloureuses osseuses de la Drépanocytose par un vaso-dilatateur artériolaire.